Glenview Trust’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.23M Buy
393,227
+90,800
+30% +$1.92M 0.13% 126
2025
Q4
$6.4M Buy
302,427
+59,151
+24% +$1.25M 0.1% 140
2025
Q3
$5.16M Buy
243,276
+44,140
+22% +$930K 0.08% 152
2025
Q2
$4.19M Buy
199,136
+32,000
+19% +$661K 0.07% 166
2025
Q1
$3.47M Buy
167,136
+17,372
+12% +$356K 0.07% 167
2024
Q4
$3.05M Buy
+149,764
New +$3.1M 0.06% 174

Other funds holding IBDW

Glenview Trust's IBDW Position: Q1 2026 in Review

Glenview Trust increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 30% in Q1 2026, buying an estimated $1.92M and bringing the position to 393,227 shares worth $8.23M. The position accounts for 0.13% of the portfolio, ranked #126.

Glenview Trust first reported a position in IBDW in Q4 2024 and has held it in 6 quarters since. 288 funds tracked by Wall St. Rank hold IBDW as of Q1 2026.

  • Glenview Trust held 393,227 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $8.23M as of Q1 2026.
  • Glenview Trust bought 90,800 iShares iBonds Dec 2031 Term Corporate ETF shares in Q1 2026, an estimated $1.92M.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.13% of Glenview Trust's portfolio in Q1 2026, its #126 holding.
  • Glenview Trust first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2024 and has held it in 6 quarters since.
  • 288 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.